USPTO serial 99740878
PERIMETER
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- EVERETT, KRISTINA L
- Law office
- TMO LAW OFFICE 139
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PERIMETER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua S. Jarvis, Esq.
Joshua S. Jarvis, Esq. Foley Hoag LLP155 Seaport BoulevardSeaport WestBoston, MA 02210-2600Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic publications in the nature of reports, white papers, and articles in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biointelligence | ACTIVE | — |
| 041 | Providing online non-downloadable publications in the nature of reports, white papers, and articles in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biointelligence | ACTIVE | — |
| 042 | Providing online non-downloadable software for viewing reports and delivering, accessing, sharing, analyzing, and visualizing data in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biointelligence; scientific and technological services, namely, data collection, analysis, and reporting in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biointelligence; providing scientific and technological information in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biointelligence; Monitoring and testing of water, air, soil, surfaces, and human and animal reservoirs for viruses, pathogens, and pharmaceutical and drug contaminants; detection of viruses, pathogens, and pharmaceutical and drug contaminants in water, air, soil, surfaces, and human and animal reservoirs; scientific and technological services, namely, bio-sample testing services for others in the fields of biosecurity, biosurveillance, bioinformatics, biointelligence, scientific research, and scientific diagnostics; scientific and technological services, namely, biosecurity surveillance for analyzing food, water, air, and environmental resource safety in the fields of viruses, pathogens, and pharmaceutical and drug contaminants; consulting services for others in the field of design, planning, and implementation project management of biosecurity initiatives related to the monitoring, testing, and detection of viruses, pathogens, and pharmaceutical and drug contaminants in water, air, soil, surfaces, and human and animal reservoirs; scientific laboratory services; scientific and technological research and development in the fields of biosecurity, biosurveillance, bioinformatics, and biointelligence; Environmental monitoring services, namely, water quality monitoring and testing for pathogen content | ACTIVE | — |
| 044 | Medical consulting in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biointelligence; providing medical information in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biointelligence; all of the foregoing services based on information collected from bio-sample monitoring and testing of water, air, soil, surfaces, and human and animal reservoirs; Medical testing for diagnostic purposes; the foregoing not related to imaging for medical purposes | ACTIVE | — |
| 045 | Surveillance services, namely, surveillance of premises for viruses, pathogens, and pharmaceutical and drug contaminants | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Perimeter Systems, Inc.
- Other trademarks owned by PERIMETER SYSTEMS, INC.
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named PERIMETER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 1, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 1, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 19, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 19, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 31, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 10, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 29, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 29, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 29, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 27, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 27, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 27, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 27, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 27, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 16, 2026 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Apr 16, 2026 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 2, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2026 | NWAP | NEW APPLICATION ENTERED | — |
| Apr 2, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |